Gujarat Inject Kerala vs ZYDUS LIFESCIENCES LTD

A side-by-side comparison of Gujarat Inject Kerala (GUJINJEC) and ZYDUS LIFESCIENCES LTD (ZYDUSLIFE) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, ZYDUS LIFESCIENCES LTD leads GUJINJEC vs ZYDUSLIFE on 9 of 14 metrics (2 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation04
  • Profitability04
  • Growth· not comparable
  • Size & financial health31
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

ZYDUSLIFE takes 4/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

57.14
P/E ratio
22.05
15.66
P/B ratio
4.09
0.00%
Dividend yield
0.09%
₹0.21
EPS
₹50.09

Profitability

ZYDUSLIFE takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

0.00%
Return on equity
21.20%
12.54%
Return on capital
21.00%
0.00%
EBITDA margin
31.00%
6.43%
Net margin
18.87%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

Revenue CAGR (3Y) even
16.35%
Profit CAGR (3Y) even
34.80%

Size & financial health

GUJINJEC takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹195 Cr
Market cap
₹1.12L Cr
₹1245.45L Cr
Revenue
₹27,148 Cr
₹125.16L Cr
Net profit
₹5,124 Cr
0.00
Debt / equity
0.31
ZYDUS LIFESCIENCES LTD
  • + ["Company has delivered good profit growth of 18.8% CAGR over last 5 years"]
Gujarat Inject Kerala full analysis ZYDUS LIFESCIENCES LTD full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.